About

Publications While At HealthPartners

selected publications

Journal Article

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. 

Lancet Oncology. 2017

Contact

full name

ExteNET Study Group collaborator

Quick Info

 

Collaboration

Co-author network

Map of science